Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children

被引:81
作者
Atanaskovic-Markovic, M
Velickovic, TC
Gavrovic-Jankulovic, M
Vuckovic, O
Nestorovic, B
机构
[1] Univ Childrens Hosp, Dept Allergol & Pulmonol, Belgrade, Serbia Monteneg
[2] Univ Belgrade, Fac Chem, Dept Biochem, Belgrade 11001, Serbia Monteneg
[3] Inst Immunol & Virol, Dept Allergol & Immunol, Belgrade, Serbia Monteneg
关键词
betalactams; cephalosporins; children; cross-reactivity; drug allergy; immediate allergic reaction; penicillins;
D O I
10.1111/j.1399-3038.2005.00280.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Penicillins and cephalosporins are the most important betalactams inducing IgE-mediated reactions. The safety of administering cephalosporins to penicillin-allergic children is a particular problem, because cephalosporin allergenic determinants have not been properly identified. A study was undertaken to evaluate the frequency of anaphylactic reactions to cephalosporins and penicillins and their cross-reactivity in a pediatric population. A prospective survey was conducted in a group of 1170 children with suspected immediate allergic reactions to cephalosporins and/or penicillins, which were examined during a period of 8 yr. In vivo (skin tests and challenges) and in vitro tests (for specific IgE) were performed with standard concentration of penicillins and cephalosporins. When 1170 children with a clinical history of allergy to penicillins and/or cephalosporins were tested in vivo for immediate hypersensitivity to betalactams, 58.3% cases overall were found to be skin or challenge test positive. Among them, 94.4% patients were positive to penicillins and 35.3% to cephalosporins. The frequency of positive reactions in the in vivo testing was in the range from 36.4% to 88.1% for penicillins and from 0.3% to 29.2% for cephalosporins. However, 31.5% of the penicillin allergic children cross-reacted to some cephalosporin. If a child was allergic to a cephalosporin, the frequency of positive reactions to penicillin was 84.2%. The cross-reactivity between cephalosporins and penicillins varied between 0.3% and 23.9%. The cross-reactivity among different generations of cephalosporins varied between 0% and 68.8%, being the highest for first and second-generation cephalosporins and 0% for third generation cephalosporins. The frequency of immediate allergic reactions to cephalosporins is considerably lower compared to penicillins, and the degree of cross-reactivity between cephalosporins and penicillins depends on the generation of cephalosporins, being higher with earlier generation cephalosporins. The cross-reactivity among cephalosporins is lower compared to cross-reactivity between penicillins and cephalosporins.
引用
收藏
页码:341 / 347
页数:7
相关论文
共 43 条
[1]  
Adkinson N. F. Jr., 1998, Clinical and Experimental Allergy, V28, P37
[2]  
Anderson John A., 1994, Current Opinion in Pediatrics, V6, P656, DOI 10.1097/00008480-199412000-00008
[3]  
ANNE S, 1995, ANN ALLERG ASTHMA IM, V74, P167
[4]   Type-I hypersensitivity to ceftriaxone and cross-reactivity with cefalexin and ampicillin [J].
Atanaskovic-Markovic, M ;
Gavrovic-Jankulovic, M ;
Velickovic, TC ;
Vuckovic, O ;
Todoric, D .
ALLERGY, 2003, 58 (06) :537-538
[5]   ALLERGIC REACTIONS TO BETA-LACTAMS - STUDIES IN A GROUP OF PATIENTS ALLERGIC TO PENICILLIN AND EVALUATION OF CROSS-REACTIVITY WITH CEPHALOSPORIN [J].
AUDICANA, M ;
BERNAOLA, G ;
URRUTIA, I ;
ECHECHIPIA, S ;
GASTAMINZA, G ;
MUNOZ, D ;
FERNANDEZ, E ;
DECORRES, LF .
ALLERGY, 1994, 49 (02) :108-113
[6]  
Baldo BA, 1999, CLIN EXP ALLERGY, V29, P744
[7]  
Baldo BA, 2000, ALLERGY CLIN IMMUNOL, V12, P206
[8]   Long persistence of IgE antibody to cefaclor [J].
Bernardini, R ;
Novembre, E ;
Lombardi, E ;
Pucci, N ;
Rossi, ME ;
Vierucci, A .
ALLERGY, 2000, 55 (10) :984-985
[9]  
Birkebaek N H, 1992, Ugeskr Laeger, V154, P331
[10]   Natural evolution of skin test sensitivity in patients allergic to β-lactam antibiotics [J].
Blanca, M ;
Torres, MJ ;
García, JJ ;
Romano, A ;
Mayorga, C ;
de Ramon, E ;
Vega, JM ;
Miranda, A ;
Juarez, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (05) :918-924